Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 2
2009 3
2010 4
2011 4
2012 2
2013 5
2014 4
2015 6
2016 7
2017 10
2018 7
2019 10
2020 6
2021 5
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Do Drug-likeness Rules Apply to Oral Prodrugs?
Protti ÍF, Rodrigues DR, Fonseca SK, Alves RJ, de Oliveira RB, Maltarollo VG. Protti ÍF, et al. Among authors: alves rj. ChemMedChem. 2021 May 6;16(9):1446-1456. doi: 10.1002/cmdc.202000805. Epub 2021 Feb 25. ChemMedChem. 2021. PMID: 33471444
Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main protease inhibitors.
Maltarollo VG, da Silva EB, Kronenberger T, Sena Andrade MM, de Lima Marques GV, Cândido Oliveira NJ, Santos LH, Oliveira Rezende Júnior C, Cassiano Martinho AC, Skinner D, Fajtová P, M Fernandes TH, Silveira Dos Santos ED, Rodrigues Gazolla PA, Martins de Souza AP, da Silva ML, Dos Santos FS, Lavorato SN, Oliveira Bretas AC, Carvalho DT, Franco LL, Luedtke S, Giardini MA, Poso A, Dias LC, Podust LM, Alves RJ, McKerrow J, Andrade SF, Teixeira RR, Siqueira-Neto JL, O'Donoghue A, de Oliveira RB, Ferreira RS. Maltarollo VG, et al. Among authors: alves rj. Future Med Chem. 2023 Jun;15(11):959-985. doi: 10.4155/fmc-2023-0034. Epub 2023 Jul 12. Future Med Chem. 2023. PMID: 37435731
Inhibitory effect of O-propargyllawsone in A549 lung adenocarcinoma cells.
Dos Santos EWP, de Sousa RC, de Franca MNF, Santos JF, Ottoni FM, Isidório RG, de Lucca Junior W, Alves RJ, Scher R, Corrêa CB. Dos Santos EWP, et al. BMC Complement Med Ther. 2023 Sep 20;23(1):333. doi: 10.1186/s12906-023-04156-9. BMC Complement Med Ther. 2023. PMID: 37730601 Free PMC article.
1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents.
Lavorato SN, Duarte MC, Lage DP, Tavares CAP, Coelho EAF, Alves RJ. Lavorato SN, et al. Among authors: alves rj. Chem Biol Drug Des. 2017 Nov;90(5):981-986. doi: 10.1111/cbdd.13024. Epub 2017 Jun 28. Chem Biol Drug Des. 2017. PMID: 28590516 Free PMC article.
New insights into the mechanism of antifungal action of 8-hydroxyquinolines.
Pippi B, Lopes W, Reginatto P, Silva FÉK, Joaquim AR, Alves RJ, Silveira GP, Vainstein MH, Andrade SF, Fuentefria AM. Pippi B, et al. Saudi Pharm J. 2019 Jan;27(1):41-48. doi: 10.1016/j.jsps.2018.07.017. Epub 2018 Jul 20. Saudi Pharm J. 2019. PMID: 30662305 Free PMC article.
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
Mendonça DVC, Tavares GSV, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Martins VT, Chávez-Fumagalli MA, Duarte MC, Humbert MV, Roatt BM, Menezes-Souza D, Alves RJ, Coelho EAF. Mendonça DVC, et al. Among authors: alves rj. Exp Parasitol. 2022 Feb;233:108205. doi: 10.1016/j.exppara.2021.108205. Epub 2021 Dec 28. Exp Parasitol. 2022. PMID: 34968460
74 results